You are here
Acute lymphoblastic leukaemia B014
In this section
Current RMA Instruments:
|Consolidated RH SOP||75 of 2012 as amended by 37 of 2016|
|Balance of Probabilities SOP||76 of 2012|
Changes from previous Instruments:
- ICD-9-CM Codes: 204.0
- ICD-10-AM Codes: C91.0
This is a cancer of immature white blood cells (lymphoblasts).
Confirming the diagnosis
A bone marrow biopsy is the definitive test for diagnosis.
The relevant medical specialist is a haematologist.
Diagnoses covered by SOP
- acute lymphoid leukaemia
- acute lymphocytic leukaemia
Conditions excluded from SOP
- acute myeloid leukaemia*
- adult T-cell leukaemia/lymphoma* (non-Hodgkin's lymphoma SOP)
- Burkitt’s lymphoma/leukaemia* (non-Hodgkin's lymphoma SOP)
- chronic lymphoid leukaemia*
- chronic myeloid leukaemia*
- non-Hodgkin’s lymphoma*
* another SOP applies
Clinical onset will be when the diagnosis was confirmed, or shortly before that time if characteristic symptoms were present, such as easy bruising/bleeding, recurrent infections or symptoms from anaemia.
The only worsening factor is for inability to obtain appropriate clinical management. The prognosis in adults is generally poor. Worsening beyond the normal progression of the disease will be difficult to establish and will require speciailist opinion.